
Mankind Pharma Ltd. (MANKIND) Pharma Share Price near 52-week high as stock trades at Rs 2,656.85
Updated: 20 Nov 2026 • 12:25 pm
Posted by:

Mankind Pharma Share Price was trading at Rs 2,656.85 as of 20 November 2026 at 12:22 PM IST, up 1.02% from the previous close of Rs 2,630. The move places Mankind Pharma Share Price close to its 52-week high, while the company’s market capitalisation stands at Rs 1,09,039.77 crore. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Mankind Pharma Share Price Today, the key facts are straightforward: the stock opened at Rs 2,624.70, touched an intraday high of Rs 2,656.85 and a low of Rs 2,621.00. Mankind Pharma Stock News is therefore centred on a near-high price event, backed by valuation, earnings-per-share and sector comparison data that help frame the current share price move.
Mankind Pharma Share Price remains relevant because the stock is trading near its one-year high while the broader Mankind Pharma Share Price Today discussion also has to account for valuation. The company’s P/E ratio is 48.44, P/B ratio is 6.18, ROE is 12.69%, ROCE is 13.24%, EPS is 54.29 and book value is Rs 425.67. Dividend yield is 0.04%. Those figures give Mankind Pharma Share Price News a clear fundamentals lens, especially when compared with the healthcare and pharmaceuticals peer set. Univest data shows a stock that is near a yearly high, but the numbers themselves, not assumptions, define the context for Mankind Pharma Share Price today.
Mankind Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,656.85 |
| Previous Close | Rs 2,630 |
| Today's Move | +Rs 26.85 (+1.02%) |
| Open | Rs 2,624.7 |
| High | Rs 2,656.85 |
| Low | Rs 2,621 |
| Market Capitalisation | Rs 1,09,039.77 crore |
Mankind Pharma Ltd. (MANKIND) traded at Rs 2,656.85 versus the previous close of Rs 2,630, a rise of 1.02%. The stock opened at Rs 2,624.7, reached a high of Rs 2,656.85 and touched a low of Rs 2,621.
Mankind Pharma Share Price Today shows a move of Rs 26.85 from the previous close, with the current price at Rs 2,656.85 and the day’s low at Rs 2,621.00. The stock opened at Rs 2,624.70 and reached Rs 2,656.85 during the current market session, which also marks the day’s high. That places Mankind Pharma Share Price close to its 52-week high and keeps the focus on the price event rather than any unverified reason. For Mankind Pharma Stock News readers, the useful comparison is simple: the stock is trading above the previous close and near the top of the day’s range, while the latest Mankind Pharma Share Price Update continues to reflect a one-year high setup. According to Univest, the event is a near-52-week-high move, not a statement about what caused it.
The current Mankind Pharma Share Price therefore matters to traders and long-term readers alike because it combines a positive day change with a price level that sits near the yearly high. Mankind Pharma Share Price Today also matters because the move has occurred without any need to infer a catalyst. The verified information only shows where the stock is trading, how far it is from the previous close and where it has moved within the day. That makes Mankind Pharma Share Price a price-led news event first and a research event second. The next section of Mankind Pharma Stock News turns to valuation and company quality, which are often more useful than a headline move alone.
Mankind Pharma Ltd. (MANKIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,09,039.77 crore |
| P/E Ratio | 48.44x |
| P/B Ratio | 6.18x |
| ROE | 12.69% |
| ROCE | 13.24% |
| EPS | Rs 54.29 |
| Book Value Per Share | Rs 425.67 |
| Dividend Yield | 0.04% |
Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 48.44x, P/B 6.18x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.
Mankind Pharma Ltd. has a market capitalisation of Rs 1,09,039.77 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.44x, P/B at 6.18x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 54.29, book value per share of Rs 425.67, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.39x, median ROE of 10.98%, median ROCE of 12.76%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.44x |
| Benchmark Median P/E | 26.39x |
| Benchmark Average P/E | 51.07x |
| Benchmark P/E Range | 0x to 1,399.41x |
| Company P/B Ratio | 6.18x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 12.69% |
| Benchmark Median ROE | 10.98% |
| Company ROCE | 13.24% |
| Benchmark Median ROCE | 12.76% |
| Company Market Capitalisation | Rs 1,09,039.77 crore |
| Benchmark Median Market Cap | Rs 742.37 crore |
Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 48.44x, which is above the benchmark median of 26.39x, a difference of +83.55%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 10.98%, a difference of +15.57%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is above the benchmark median of 12.76%, a difference of +3.76%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,14,720.11 | 39.49 | 3.23 | 11.83 | 16 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 1,03,625.56 | 26.06 | 2.64 | 9.93 | 12.76 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,16,603.91 | 41.71 | 3.01 | 11.69 | 13.75 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,201.71 | 28.64 | 4.3 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,25,460.5 | 92.83 | 20.52 | 18.31 | 18.2 |
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 48.44x compared with the displayed peer median of 39.49x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 1,09,039.77 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Mankind Pharma
- Mankind Pharma Share Price is Rs 2,656.85, which is close to its 52-week high and above the previous close of Rs 2,630.
- Mankind Pharma Share Price Today shows a 1.02% rise, with the day’s range between Rs 2,621.00 and Rs 2,656.85.
- The company’s market capitalisation is Rs 1,09,039.77 crore, which places Mankind Pharma Share Price in a large valuation bracket by market value alone.
- P/E is 48.44 and P/B is 6.18, both above the industry median in the same-industry benchmark.
- ROE of 12.69%, ROCE of 13.24%, EPS of 54.29 and book value of Rs 425.67 provide the core fundamental snapshot for Mankind Pharma Stock News.
About Mankind Pharma
Mankind Pharma Share Price belongs to Mankind Pharma Ltd., which is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The latest Univest view on Mankind Pharma Share Price today is built around these category labels and the company’s reported financial metrics. Mankind Pharma Stock News often sits within healthcare market coverage because the stock is among the better-known listed names in the same industry benchmark used here. The latest share price update is therefore not just a price headline; it is also a way to place the company within its sector and peer universe. For readers tracking Mankind Pharma Share Price and Mankind Pharma Stock News, the company profile is best understood through this classification and the financial numbers already visible in the latest record.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Mankind Pharma Share Price near its 52-week high?
Ans. Mankind Pharma Share Price is trading at Rs 2,656.85, close to its yearly high range. The latest Univest figures confirm the near-high price event, but they do not identify a company-specific catalyst.
What is Mankind Pharma Share Price today?
Ans. Mankind Pharma Share Price today is Rs 2,656.85 as of 20 November 2026 at 12:22 PM IST. It is above the previous close of Rs 2,630 and was trading near the day’s high.
How much did Mankind Pharma Share Price move today?
Ans. Mankind Pharma Share Price moved up by Rs 26.85, or 1.02%, from the previous close. The stock opened at Rs 2,624.70 and touched Rs 2,656.85 during the session.
What is the market capitalisation of Mankind Pharma?
Ans. Mankind Pharma has a market capitalisation of Rs 1,09,039.77 crore. That makes Mankind Pharma Share Price relevant in the healthcare space by market value, even before comparing valuation multiples.
How does Mankind Pharma Share Price compare with the industry P/E?
Ans. Mankind Pharma Share Price carries a P/E of 48.44, which is above the industry median of 26.39 and below the industry average of 51.07. The comparison uses a same-industry benchmark of 199 companies.
Is Mankind Pharma Share Price expensive on book value?
Ans. Mankind Pharma Share Price has a P/B ratio of 6.18, which is above the industry median of 2.83 and above the industry average of 3.35. That makes the valuation rich relative to the benchmark set.
What do ROE and ROCE show for Mankind Pharma?
Ans. Mankind Pharma reports ROE of 12.69% and ROCE of 13.24%. Both are above the same-industry medians, which adds useful context for Mankind Pharma Share Price alongside the valuation ratios.
What does the latest revenue figure show for Mankind Pharma?
Ans. The latest quarter revenue disclosed is Rs 4,337.86 crore for Sep 2026. That figure helps frame Mankind Pharma Share Price within a current operating snapshot rather than only a market-price move.
Track Mankind Pharma Share Price on Univest
Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Mankind Pharma Share Price on Univest for live share price updates, company ratios, 52-week levels, market capitalisation, revenue snapshot and peer comparison. Univest also helps readers follow Mankind Pharma Share Price Today, Mankind Pharma Stock News and the broader Mankind Pharma Share Price Update in one place.
Recent Articles

LG ELECTRONICS INDIA LTD (LGEINDIA) Share Price Rise Streak: Second Straight Session Holds Above Rs 1,749
20 November 2026

Poonawalla Fincorp Ltd. (POONAWALL) 52 Week High Streak Holds For Second Straight Session
20 November 2026

GMR Power and Urban Infra (GMRP&UI) Share Price Near 52-Week Low as Stock Trades at Rs 87.56
20 November 2026

GOEL CONSTRUCTION COMPANY LIMI (GOELCONS) Share Price Near All-Time High, Rs 584 Today
20 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
LG ELECTRONICS INDIA LTD (LGEINDIA) Share Price Rise Streak: Second Straight Session Holds Above Rs 1,749
Poonawalla Fincorp Ltd. (POONAWALL) 52 Week High Streak Holds For Second Straight Session
GMR Power and Urban Infra (GMRP&UI) Share Price Near 52-Week Low as Stock Trades at Rs 87.56
GOEL CONSTRUCTION COMPANY LIMI (GOELCONS) Share Price Near All-Time High, Rs 584 Today
Aditya Birla Capital (ABCAPITAL) Share Price Near 52-Week High at Rs 422.05

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





